Human Pathology
Volume 41, Issue 4 , Pages 477-484 , April 2010

IMP3 expression is correlated with histologic grade of lung adenocarcinoma

  • Jennifer J. Findeis-Hosey, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
  • ,
  • Qi Yang, AAS

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
  • ,
  • Betsy O. Spaulding, BS

      Affiliations

    • Dako North America, Carpinteria, CA 93013, USA
  • ,
  • Hanlin L. Wang, MD, PhD

      Affiliations

    • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
  • ,
  • Haodong Xu, MD, PhD

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    • Corresponding Author InformationCorresponding author. Department of Pathology and Laboratory Medicine, Box 626, University of Rochester Medical Center, Elmwood 601, Rochester, NY 14642, USA.

Received 28 May 2009 ,Revised 30 September 2009 ,Accepted 7 October 2009.

References 

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. Devesa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117:294–299
  3. Sun Z, Aubry MC, Deschamps C, et al. Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases. J Thorac Cardiovasc Surg. 2006;131:1014–1020
  4. Sica G, Travis WD, Moreira A. Strong correlation between solid and micropapillary subtypes of lung adenocarcinoma (AD) in primary and metastatic sites (Abstract). Mod Pathol. 2009;22(Suppl I):361A–362A
  5. Travis WD, Colby T, Corrin B, et al. Tumors of the lung. In:  Kleihues P,  Sobin LH editor. WHO classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon, France: IARC press; 2004;p. 38
  6. Zell JA, Ou SH, Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol. 2005;23:8396–8405
  7. Dacic S. Pulmonary preneoplasia. Arch Pathol Lab Med. 2008;132:1073–1078
  8. Sartori G, Cavazza A, Bertolini F, et al. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis. Am J Clin Pathol. 2008;129:202–210
  9. Nielsen J, Christiansen J, Lykke-Andersen J, et al. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19:1262–1270
  10. Wang T, Fan L, Watanabe Y, et al. L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br J Cancer. 2003;88:887–894
  11. Liao B, Hu Y, Herrick DJ, et al. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem. 2005;280:18517–18524
  12. Yantiss RK, Woda BA, Fanger GR, et al. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol. 2005;29:188–195
  13. Mueller-Pillasch F, Lacher U, Wallrapp C, et al. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene. 1997;14:2729–2733
  14. Jiang Z, Chu PG, Woda BA, et al. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol. 2006;7:556–564
  15. Xu H, Bourne PA, Spaulding BO, et al. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Hum Pathol. 2007;38:555–563
  16. Simon R, Bourne PA, Yang Q, et al. Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not. Hum Pathol. 2007;38:1178–1183
  17. Li C, Zota V, Woda BA, et al. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations. Mod Pathol. 2007;20:1263–1268
  18. Pryor JG, Bourne PA, Yang Q, et al. IMP-3 is a novel progression marker in malignant melanoma. Mod Pathol. 2008;21:431–437
  19. Hanley KZ, Facik MS, Bourne PA, et al. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions. Cancer. 2008;114:49–56
  20. Vikesaa J, Hansen TV, Jonson L, et al. RNA-binding IMPs promote cell adhesion and invadopodia formation. Embo J. 2006;25:1456–1468
  21. Istvanic S, Fanger G, Fraire A, et al. Spectrum of KOC (K homology domain containing protein over-expressed in cancer) immunostaining among carcinomas of different sites. Mod Pathol. 2005;18:298A–299A
  22. Bellezza G, Cavaliere A, Sidoni A. IMP3 expression in non-small cell lung cancer. Hum Pathol. 2009;40:1205–1206
  23. In:  Edge SB,  Byrd DR,  Compton CC, et al. editor. AJCC cancer staging manual 7th edition. Chicago, IL: Springer; 2010;p. 253–270
  24. Chao W, D'Amore PA. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev. 2008;19:111–120
  25. Foulstone E, Prince S, Zaccheo O, et al. Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol. 2005;205:145–153
  26. Quinn KA, Treston AM, Unsworth EJ, et al. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem. 1996;271:11477–11483
  27. Takanami I, Imamuma T, Hashizume T, et al. Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma. J Surg Oncol. 1996;61:205–208

PII: S0046-8177(09)00369-4

doi: 10.1016/j.humpath.2009.10.004

Human Pathology
Volume 41, Issue 4 , Pages 477-484 , April 2010